New Treatments & Clinical Trials for Iron Deficiency Anemia

Iron deficiency anemia is the most common nutritional deficiency worldwide, occurring when the body lacks enough iron to produce adequate hemoglobin, leading to fatigue, weakness, reduced exercise tolerance, and impaired cognitive function. Underlying causes range from poor dietary intake to chronic blood loss, and treatment must address both the deficiency and its source.

What's actually going on in research

Intravenous iron formulations have become increasingly favored over oral iron for patients with absorption issues or intolerance, and several newer IV iron preparations allow faster infusion and single-dose repletion. Trials are comparing oral and IV approaches across various patient populations, studying the optimal timing of iron therapy in heart failure and chronic kidney disease, and investigating whether correcting iron deficiency independent of hemoglobin levels improves outcomes.

What to know before you search

Eligibility depends on hemoglobin level, ferritin and transferrin saturation, underlying cause, and whether oral iron has already been tried.

What types of trials are currently open

• IV iron formulation trials — Comparing newer intravenous iron preparations for speed, safety, and degree of iron repletion.
• Oral iron trials — Testing formulations and dosing schedules that maximize absorption while reducing gastrointestinal side effects.
• Heart failure trials — Evaluating whether iron therapy improves exercise capacity and reduces hospitalizations in iron-deficient heart failure.
• Chronic kidney disease trials — Studying iron repletion strategies in patients on dialysis or with advanced kidney disease.
• Pediatric trials — Testing iron supplementation strategies in children and adolescents with deficiency anemia.